{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:20:06Z","timestamp":1790256006970,"version":"4.1.0"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IMI Pharmacog","award":["115009"],"award-info":[{"award-number":["115009"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184822","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T13:30:58Z","timestamp":1505741458000},"page":"e0184822","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus)"],"prefix":"10.1371","volume":"12","author":[{"given":"Anisur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Lamberty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Languille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-1935","authenticated-orcid":true,"given":"Fabien","family":"Pifferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Aujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: genes, proteins and therapy","volume":"81","author":"D.J. Selkoe","year":"2001","journal-title":"Physiol. Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"J.A. Hardy","year":"1992","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimers disease","volume":"368","author":"K. Blennow","year":"2006","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","article-title":"Alzheimer&apos;s disease: molecular understanding predictsamyloid-based therapeutics","volume":"43","author":"D. Selkoe","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.0308627101","article-title":"Default-mode network activity distinguishes Alzheimer&apos;s disease from healthy aging: evidence from functional MRI","volume":"101","author":"M.D. Greicius","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation","volume":"219","author":"J.T. Coyle","year":"1983","journal-title":"Science"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer&apos;s disease","volume":"45","author":"M.R. Hynd","year":"2004","journal-title":"Neurochem. Int"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biopha.2008.02.005","article-title":"Current approaches in the treatment of Alzheimer&apos;s disease","volume":"62","author":"R. S. Shah","year":"2008","journal-title":"Biomed. Pharmacother"},{"issue":"8000","key":"ref9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer\u2019s disease","volume":"2","author":"P. Davies","year":"1976","journal-title":"Lancet"},{"issue":"6","key":"ref10","first-page":"557","article-title":"Efiicacy and safety of cholinesterase inhibitors in Alzheimer\u2019s disease: a meta-analysis","volume":"169","author":"K.L. Lanctot","year":"2003","journal-title":"C.M.A.J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependant signalling pathway","volume":"27","author":"G.M. Shankar","year":"2007","journal-title":"J. Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A beta-oligomer induced abberation in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease","volume":"27","author":"P.N. Lacor","year":"2007","journal-title":"J. Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"S. Lesne","year":"2006","journal-title":"Nature"},{"key":"ref14","first-page":"23","article-title":"Recent advances in the neurochemistry of Alzheimer\u2019s disease","volume":"48","author":"P. Davies","year":"1987","journal-title":"J. Clin. Psychiatry"},{"key":"ref15","first-page":"S9","article-title":"Neurochemical changes in the aging human brain: implications for behavioural impairment and neurodegenerative disease","volume":"53","author":"R. Strong","year":"1998","journal-title":"Geriatrics"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","article-title":"Alzheimer&apos;s disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies","volume":"68","author":"D. S. Auld","year":"2002","journal-title":"Prog. Neurobiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/17425255.2014.915028","article-title":"Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer\u2019s disease","volume":"10","author":"D. Prvulovic","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"ref18","first-page":"CD001190","article-title":"Donepezil for dementia due to Alzheimer\u2019s disease","author":"J. Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3892\/mmr.2012.1102","article-title":"Expression of APP, BACE1, AChE and ChAT in an AD model in rats and the effect of donepezil hydrochloride treatment","volume":"6","author":"Q. Li","year":"2012","journal-title":"Mol. Med. Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1358\/mf.2000.22.2.796070","article-title":"Donepezil, a centrally acting acetyl ChE inhibitor, alleviates learning deficits in hypocholinergic models in rats","volume":"22","author":"H. Ogura","year":"2000","journal-title":"Methods Find. Exp. Clin. Pharmacol"},{"issue":"13","key":"ref21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14656566.2014.945907","article-title":"Efficacy of memantine hydrochloride once-daily in Alzheimer\u2019s disease","volume":"15","author":"A. Kurz","year":"2014","journal-title":"Expert Opin. Pharmacother"},{"key":"ref22","first-page":"CD003154","article-title":"Memantine for dementia","author":"R. McShane","year":"2006","journal-title":"Cochrane Database Syst. Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-2007-11409","article-title":"Memantine treatment in patients with mild to moderate Alzheimer\u2019s disease: results of a randomised, double-blind, placebo-controlled 6 month study","volume":"11","author":"S. Bakchine","year":"2007","journal-title":"J. Alzheimers Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","article-title":"Memantine improves spatial learning in a transgenic mouse model of Alzheimer\u2019s disease","volume":"311","author":"R. Minkeviciene","year":"2004","journal-title":"J. Pharmacol. Exp. Ther"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3233\/JAD-2010-101632","article-title":"Memantine in behavioural variant fronto temporal dementia","volume":"23","author":"M. Vercelletto","year":"2011","journal-title":"J. Alzheimers Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1523\/JNEUROSCI.4883-05.2006","article-title":"Low doses of memantine disrupt memory in adult rats","volume":"26","author":"C. Creeley","year":"2006","journal-title":"J. Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.phrs.2010.02.009","article-title":"Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systemic review","volume":"61","author":"D. Repantis","year":"2010","journal-title":"Pharmacol. Res"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4088\/PCC.v05n0602","article-title":"Long-term cholinesterase inhibitor therapy for Alzheimer\u2019s disease: practical considerations for the primary care physician","volume":"5","author":"D.S. Geldmacher","year":"2003","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000017126","article-title":"The effects of donepezil in Alzheimer\u2019s disease results from a multinational trial","volume":"10","author":"A. Burns","year":"1999","journal-title":"Dement. Geriatr. Cogn. Disord"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/gps.1949","article-title":"Improvement in behavioural symptoms in patients with moderate to severe Alzheimer\u2019s disease by memantine: a pooled data analysis","volume":"23","author":"S. Gauthier","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","article-title":"Effectiveness of cholinesterase inhibitors and mematine for treating dementia: evidence review for a clinical practice guideline","volume":"148","author":"P. Raina","year":"2008","journal-title":"Ann. Intern. Med"},{"issue":"2\u20133","key":"ref32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000357568","article-title":"We can treat Alzheimer\u2019s disease successfully in mice but not in men: failure in translation? A perspective","volume":"13","author":"M. Windisch","year":"2014","journal-title":"Neurodegener. Dis"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/j.ddtec.2012.04.001","article-title":"Animal model of Alzheimer\u2019s disease and drug development","volume":"10","author":"B. Laurijssens","year":"2013","journal-title":"Drug Discov. Today Technol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.arr.2011.07.001","article-title":"The grey mouse lemur: a non-human primate model for ageing studies","volume":"11","author":"S. Languille","year":"2012","journal-title":"Ageing Res. Rev"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.neurobiolaging.2010.09.009","article-title":"Age-related cerebral atrophy in non-human primates predicts cognitive impairments","volume":"33","author":"J.L. Picq","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"e0146238","DOI":"10.1371\/journal.pone.0146238","article-title":"Jumping stand apparatus reveals rapidly specific age-related cognitive impairments in mouse lemur primates","volume":"10","author":"JL. Picq","year":"2015","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1101\/lm.48803","article-title":"Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning","volume":"10","author":"L.A. Graves","year":"2003","journal-title":"Learn. Mem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2005.06.057","article-title":"REM sleep deprivation inhibits LTP in vivo in area CA1 of rat hippocampus","volume":"388","author":"E.Y. Kim","year":"2005","journal-title":"Neurosci. Lett"},{"key":"ref39","article-title":"Experimental sleep deprivation as a tool to test memory deficits in rodents","author":"V. Colavito","year":"2013","journal-title":"Front. Syst. Neurosci"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbr.2011.09.017","article-title":"The neuroprotective effect of vitamin E on chronic sleep deprivation-induced memory impairment: the role of oxidative stress","volume":"226","author":"K.H. Alzoubi","year":"2012","journal-title":"Behav. Brain Res"},{"key":"ref41","article-title":"Sleep deprivation impairs spatial retrieval but not spatial learning in the non-human primate grey mouse lemur","author":"A. Rahman","year":"2013","journal-title":"PLoS One"},{"issue":"7\u20138","key":"ref42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00018-007-6457-8","article-title":"Effects of sleep deprivation on neural functioning: an integrative review","volume":"64","author":"T.W. Boonstra","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbr.2015.02.040","article-title":"Short-term sleep deprivation impairs spatial working memory and modulates expression levels of ionotropic glutamate receptor subunits in hippocampus","volume":"286","author":"M. Xie","year":"2015","journal-title":"Behav Brain Res"},{"key":"ref44","unstructured":"Weatherall, FRS. D. The use of non-human primate in research, The Weatherall report. 2006."},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/07420528.2011.654019","article-title":"Effects of dietary resveratrol on the sleep-wake cycle in the non-human primate grey mouse lemur (<italic>Microcebus murinus<\/italic>)","volume":"29","author":"F. Pifferi","year":"2012","journal-title":"Chronobiol. Int"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1532-5415.2010.03048.x","article-title":"Once-daily memantine: pharmacokinetic and clinical considerations","volume":"58","author":"I.H. Gomolin","year":"2010","journal-title":"J. Am. Geriatr. Soc"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clpt.2005.10.005","article-title":"Pharmacokinetic study of memantine in healthy and renally impaired subjects","volume":"79","author":"A. Periclou","year":"2006","journal-title":"Clin. Pharmacol. Ther"},{"issue":"5","key":"ref48","first-page":"236","article-title":"Free radical scavenging effect of donepezil as the possible contribution to its memory enhancing activity in mice","volume":"64","author":"S. Umukoro","year":"2014","journal-title":"Drug Res. (Stuttg)"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2012.01.008","article-title":"Memory defect induced by \u00df-amyloid plus glutamate receptor agonist is alleviated by catalpol and donepezil through different mechanisms","volume":"1441","author":"Z. Xia","year":"2012","journal-title":"Brain Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer\u2019s-like neuropathology in transgenic mice","volume":"176","author":"H. Martinez-Coria","year":"2010","journal-title":"Am. J. Pathol"},{"key":"ref51","first-page":"57","article-title":"Memantine leads to behavioral improvement and amyloid reduction in Alzheimer\u2019s-disease-model transgenic mice shown as by micromagnetic resonance imaging","volume":"224","author":"H. Scholtzova","year":"2008","journal-title":"J. Neurosci. Res"},{"issue":"1\u20133","key":"ref52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2012.12.023","article-title":"Characterization of cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease and effects of donepezil and memantine","volume":"703","author":"A. Nagakura","year":"2013","journal-title":"Eur. J. Pharmacol"},{"issue":"5\u20136","key":"ref53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuropharm.2011.06.008","article-title":"Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats","volume":"61","author":"J. Ihalainen","year":"2011","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"ref54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0166-4328(90)90161-7","article-title":"The effect of 3-h and 6-h sleep deprivation on sleep and EEG spectra of the rat","volume":"36","author":"I. Tobler","year":"1990","journal-title":"Behav. Brain Res"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/sleep\/33.11.1465","article-title":"Coping with sleep deprivation: shifts in regional brain activity and learning strategy","volume":"33","author":"R. Hagewoud","year":"2010","journal-title":"Sleep"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-011-2456-4","article-title":"The scopolamine model as a pharmacodynamic marker in early drug development","volume":"220","author":"R.A. Lenz","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0166-4328(93)90130-I","article-title":"The effects of novel ChE inhibitors and selective muscarinic receptor agonists in test of reference and working memory","volume":"57","author":"G.R. Dawson","year":"1993","journal-title":"Behav. Brain Res"},{"issue":"4","key":"ref58","first-page":"355","article-title":"Reversal of scopolamine induced spatial memory deficits in rats by TAK-147","volume":"23","author":"Z. Chen","year":"2002","journal-title":"Acta Pharmacol. Sin"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-013-3152-3","article-title":"Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer\u2019s disease","volume":"230","author":"A. Easton","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"44","key":"ref60","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1523\/JNEUROSCI.4045-08.2008","article-title":"Cholinergic augmentation modulates visual task performance in sleep-deprived young adults","volume":"28","author":"L.Y. Chuah","year":"2008","journal-title":"J. Neurosci"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/sleep\/32.8.999","article-title":"Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation","volume":"32","author":"L.Y. Chuah","year":"2009","journal-title":"Sleep"},{"issue":"1\u20133","key":"ref62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-2999(96)00072-6","article-title":"An inverted U-shaped curve for hepatylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors","volume":"302","author":"D Braida","year":"1996","journal-title":"Eur. J. Pharmacol"},{"issue":"1\u20132","key":"ref63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(81)90500-X","article-title":"Cholinergic receptor interactions and their effects on long-term memory processing","volume":"215","author":"J.F. Flood","year":"1981","journal-title":"Brain Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1523\/JNEUROSCI.10-01-00283.1990","article-title":"Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations","volume":"10","author":"R.L. Michaels","year":"1990","journal-title":"J. Neurosci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.1993.tb23021.x","article-title":"Neurotransmitters and second messengers in aging and Alzheimer\u2019s disease","volume":"695","author":"P.T. Francis","year":"1993","journal-title":"Ann. NY. Acad. Sci"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0197-4580(89)90143-7","article-title":"Excitatory amino acids and Alzheimer\u2019s disease","volume":"10","author":"J.T. Greenamyre","year":"1989","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.euroneuro.2005.06.005","article-title":"Cognitive evaluation of disease modifying efficacy of galantamine and memantine in APP23 model","volume":"16","author":"D. Van Dam","year":"2006","journal-title":"Eur. Neuropsychopharmacol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.05.023","article-title":"Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus","volume":"85","author":"E. Tarragon","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(97)13452-8","article-title":"The NMDA antagonist memantine impairs classical eyeblink conditioning in humans","volume":"224","author":"M.M. Schugens","year":"1997","journal-title":"Neurosci. Lett"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1101\/lm.33701","article-title":"Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans","volume":"8","author":"T.H. Rammsayer","year":"2001","journal-title":"Neurobiol. Learn. Mem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresbull.2007.01.007","article-title":"Effects of NMDA receptor antagonist memantine on mismatch negativity","volume":"72","author":"M. Korostenskaja","year":"2007","journal-title":"Brain Res. Bull"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"P.N. Tariot","year":"2004","journal-title":"JAMA"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archneur.63.1.49","article-title":"A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease","volume":"63","author":"B. Reisberg","year":"2006","journal-title":"Arch. Neurol"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1601-183X.2005.00149.x","article-title":"Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer\u2019s disease?","volume":"5","author":"N. Bons","year":"2006","journal-title":"Genes Brain Behav"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fnbeh.2014.00446","article-title":"Deficits of psychomotor and mnesic functions across aging in mouse lemur primates","volume":"8","author":"S. Languille","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neurobiolaging.2012.10.020","article-title":"Effects of memantine and galantamine on cognitive performance in aged rhesus macaques","volume":"34","author":"JS Schneider","year":"2013","journal-title":"Neurobiol Aging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T12:39:51Z","timestamp":1570106391000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184822"}},"subtitle":[],"editor":[{"given":"Stephen D","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":76,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184822","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}